BBIO- Bridgebio Pharma, Inc.

Across the last three months, Bridgebio Pharma, Inc.'s insiders have reduced their positions by a net 56,980 shares worth roughly $4.6M.

BBIO sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Homcy Charles J	919.9K	-	-
CEO	Kumar Neil	497.0K	$34.30M	-
CFO	Trimarchi Thomas	336.5K	$26.88M	-
Other	Apuli Maricel	122.7K	$9.80M	-
Dir	Cook Jennifer E.	120.8K	$10.15M	-

Buys and sells only

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 19, 2026	Kumar Neil	Chief Executive Officer	Sell	28,053	$71.39	$2,002,717.48	-10.7%	-	-
Feb 17, 2026	Scott Randal W.45	Director	Sale+OE	10,000	$75.46	$754,556.60	-46.3%	-	-
Feb 17, 2026	Trimarchi Thomas	President And CFO	Sell	13,600	$74.72	$1,016,147.12	-3.9%	-	-
Feb 17, 2026	Apuli Maricel	Chief Accounting Officer	Sell	510	$74.31	$37,898.10	-0.4%	-	-
Feb 11, 2026	Kumar Neil	Chief Executive Officer	Sell	80,000	$71.86	$5,748,666.24	-1.5%	-	-
Jan 9, 2026	Kumar Neil	Chief Executive Officer	Sell	80,000	$75.54	$6,043,168.23	-1.7%	-2.2%	-
Dec 15, 2025	Kumar Neil	Chief Executive Officer	Sale+OE	30,011	$74.64	$2,239,902.15	-11.6%	-4.7%	-
Dec 8, 2025	Apuli Maricel	Chief Accounting Officer	Sell	2,000	$74.26	$148,520.00	-1.5%	-11.6%	-
Dec 5, 2025	Kumar Neil	Chief Executive Officer	Sell	80,000	$73.86	$5,908,475.89	-1.7%	-10.0%	-
Nov 20, 2025	Kumar Neil	Chief Executive Officer	Sell	26,156	$65.84	$1,722,223.69	-10.3%	+14.4%	-